Modular Medical submits next-gen insulin pump for FDA clearance
4.7 (97) · $ 16.00 · In stock
Modular Medical (Nasdaq:MODD) announced today that it submitted its next-generation MODD1 insulin pump to the FDA for 510(k) clearance.
Connected Insulin Delivery Devices - T1D Exchange
A Guide to Insulin Pumps and New Diabetes Technology
Interius BioTherapeutics raises $76M Series A - Drug Delivery Business
Pump maker Modular Medical names former Insulet CEO to board
Automated Pump: FDA Approves Next-Gen Insulin System, SciFocus
A narrative commentary about interoperability in medical devices and data used in diabetes therapy from an academic EU/UK/US perspective
A Guide to Insulin Pumps and New Diabetes Technology
Olympus updates reprocessing instructions for Duodenoscopes - MassDevice
Novo Nordisk inks diabetes dev partnership with Lyfebulb - MassDevice
